Inventor · disambiguated record
Robert George Boyle
Also filed as: BOYLE ROBERT G · BOYLE ROBERT GEORGE
23 granted patents·14 pending applications·72 citations·filing 2001–2021
94Inventor score
Files withSENTINEL ONCOLOGY LTD14ASTEX THERAPEUTICS LTD8MILLENNIUM PHARM INC4BERDINI VALERIO3BOYLE ROBERT GEORGE3
Top patents by PatentIndex Score
37 records- 0188US11884656B2Pyrrole derivatives as PLK1 inhibitorsSENTINEL ONCOLOGY LTD·Filed 2021·Granted Jan 30, 2024·1 cites·20 claims
- 0286US10344033B22-aminoquinazoline derivatives as P70S6 kinase inhibitorsSENTINEL ONCOLOGY LTD·Filed 2016·Granted Jul 9, 2019·6 cites·20 claims
- 0384US9630931B2Pharmaceutically active pyrazine derivativesSENTINEL ONCOLOGY LTD·Filed 2012·Granted Apr 25, 2017·3 cites·17 claims
- 0483US7202244B2Chk-1 inhibitorsMILLENNIUM PHARM INC·Filed 2003·Granted Apr 10, 2007·16 cites·7 claims
- 0581US10010547B2Pharmaceutical compoundsCASCADIAN THERAPEUTICS INC·Filed 2015·Granted Jul 3, 2018·7 cites·23 claims
- 0680US8546407B2Ortho-condensed pyridine and pyrimidine derivatives (e.g., purines) as protein kinases inhibitorsBERDINI VALERIO·Filed 2005·Granted Oct 1, 2013·4 cites·18 claims
- 0780US8343953B2Pharmaceutical compoundsASTEX THERAPEUTICS LTD·Filed 2006·Granted Jan 1, 2013·6 cites·24 claims
- 0879US8716287B2Pharmaceutical compoundsBOYLE ROBERT GEORGE·Filed 2011·Granted May 6, 2014·6 cites·22 claims
- 0978US11208405B2Pyrrole derivatives as PLK1 inhibitorsSENTINEL ONCOLOGY LTD·Filed 2018·Granted Dec 28, 2021·2 cites·17 claims
- 1078US8461339B2Pharmaceutical compoundsBOYLE ROBERT GEORGE·Filed 2009·Granted Jun 11, 2013·4 cites·17 claims
- 1176US10973817B2Pharmaceutical compoundsSENTINEL ONCOLOGY LTD·Filed 2018·Granted Apr 13, 2021·1 cites·25 claims
- 1276US9006430B2Ortho-condensed pyridine and pyrimidine derivatives (e.g., purines) as proteinASTEX THERAPEUTICS LTD·Filed 2014·Granted Apr 14, 2015·2 cites·20 claims
- 1376US8691806B2Pyrazole derivatives as protein kinase modulatorsBERDINI VALERIO·Filed 2012·Granted Apr 8, 2014·2 cites·20 claims
- 1476US8541461B2Pharmaceutical combinations comprising pyrazole derivatives as protein kinase modulatorsTHOMPSON NEIL THOMAS·Filed 2006·Granted Sep 24, 2013·2 cites·26 claims
- 1575US8809336B2Ortho-condensed pyridine and pyrimidine derivatives (e.g., purines) as protein kinases inhibitorsASTEX THERAPEUTICS LTD·Filed 2013·Granted Aug 19, 2014·2 cites·13 claims
- 1673US8247576B2Pyrazole derivatives as protein kinase modulatorsBERDINI VALERIO·Filed 2004·Granted Aug 21, 2012·5 cites·8 claims
- 1769US8796293B2Purine and deazapurine derivatives as pharmaceutical compoundsDAVIES THOMAS GLANMOR·Filed 2007·Granted Aug 5, 2014·3 cites·17 claims
- 1866US11786524B2Pharmaceutical compoundsSENTINEL ONCOLOGY LTD·Filed 2021·Granted Oct 17, 2023·0 cites·19 claims
- 1962US9283226B2Pyrazole derivatives as protein kinase modulatorsASTEX THERAPEUTICS LTD·Filed 2014·Granted Mar 15, 2016·0 cites·20 claims
- 2061US10730882B22-aminoquinazoline derivatives as P70S6 kinase inhibitorsSENTINEL ONCOLOGY LTD·Filed 2019·Granted Aug 4, 2020·0 cites·18 claims
- 2154US2008234276A1Heterocyclic Triazines as Hypoxic Selective Protein Kinase InhibitorsSENTINEL ONCOLOGY LTD·Filed 2006·Application pending·0 cites
- 2254US2010048540A1Heterocyclic N-Oxides as Hypoxic Selective Protein Kinase InhibitorsSENTINEL ONCOLOGY LTD·Filed 2006·Application pending·0 cites
- 2353US2016250187A1Pyrazole derivatives as protein kinase modulatorsASTEX THERAPEUTICS LTD·Filed 2016·Application pending·0 cites
- 2453US2024140908A1A pharmaceutical salt of an arylpyrrole derivativeSENTINEL ONCOLOGY LTD·Filed 2021·Application pending·0 cites
- 2553US2005245563A1Chk-1 inhibitorsMILLENNIUM PHARM INC·Filed 2004·Application pending·0 cites
- 2650US2009082370A1Pharmaceutical Combinations of PK Inhibitors and Other Active AgentsTHOMPSON NEIL THOMAS·Filed 2007·Application pending·0 cites
- 2747US2022348565A1Pharmaceutical compoundsSENTINEL ONCOLOGY LTD·Filed 2020·Application pending·0 cites
- 2846US2017247341A1Pharmaceutically active pyrazine derivativesSENTINEL ONCOLOGY LTD·Filed 2017·Application pending·0 cites
- 2945US2009270416A1N-OXIDES OF DIARYLUREA DERIVATIVES AND THEIR USE AS Chk1 INHIBITORS FOR THE TREATMENT OF CANCERSENTINEL ONCOLOGY LTD·Filed 2007·Application pending·0 cites
- 3044US2009253718A1Pharmaceutical CompoundsASTEX THERAPEUTICS LTD·Filed 2007·Application pending·0 cites
- 3143US2006035920A1Chk-1 inhibitorsMILLENNIUM PHARM INC·Filed 2005·Application pending·0 cites
- 3242US10144726B2Modulators of the p70S6 kinase for use in the treatment of brain disorders and triple-negative breast cancerSENTINEL ONCOLOGY LTD·Filed 2016·Granted Dec 4, 2018·0 cites·20 claims
- 3342US2008275029A1Compounds for Treating Protein-Kinase Mediated DisordersASTEX THERAPEUTICS LTD·Filed 2005·Application pending·0 cites
- 3441US2009099213A1Ortho-Condensed Pyridine and Pyrimidine Derivatives (e.g., Purines) as Protein Kinases InhibitorsASTEX THERAPEUTICS LTD·Filed 2005·Application pending·0 cites
- 3540US2005176733A1Chk-1 inhibitorsMILLENNIUM PHARM INC·Filed 2005·Application pending·0 cites
- 3635US8716473B2Substituted benzotriazines and quinoxalines as inhibitors of P7OS6 kinaseBOYLE ROBERT GEORGE·Filed 2010·Granted May 6, 2014·0 cites·22 claims
- 3733US6852744B2Pyrrolidine derivatives and their use as chymase inhibitorDAINIPPON PHARMACEUTICAL CO·Filed 2001·Granted Feb 8, 2005·0 cites·45 claims
Join the waitlist — get patent alerts
Get an alert when Robert George Boyle files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →